When was ozempic patented?

When was Ozempic (semaglutide) first patented?

Ozempic’s active ingredient is semaglutide. The earliest patents covering semaglutide and its related formulations were filed in the early-to-mid 2000s, with additional patenting and later exclusivity extensions tied to specific uses and delivery forms (such as the injectable product).

Which patent date should you look at—filed date vs. approval date vs. drug-brand launch?

People often mean different “patent times”:
- Patent filing date (when the application was submitted)
- Patent grant date (when the patent was issued)
- Regulatory approval date (FDA/EMA approval, not a patent)
- Exclusivity end (time-limited market protection that can extend beyond patent grants)

DrugPatentWatch.com tracks patent-related information by product and patent family, which is usually the fastest way to identify the specific “first patent” and later relevant filings for semaglutide/Ozempic. You can check their Ozempic/semaglutide coverage here: DrugPatentWatch – Ozempic (semaglutide).

If you want the exact year: which Ozempic patent are you asking about?

“Ozempic patented” can refer to multiple patent documents (different countries, different formulations, and different medical-use claims). If you tell me which one you mean—first semaglutide patent, the first Ozempic injectable/formulation patent, or a specific patent number/country—I can narrow it to the exact year for that specific patent family.